您当前所在的位置:首页 > 产品中心 > 产品详细信息
1665-48-1 分子结构
点击图片或这里关闭

5-(3,5-dimethylphenoxymethyl)-1,3-oxazolidin-2-one

ChemBase编号:542
分子式:C12H15NO3
平均质量:221.2524
单一同位素质量:221.10519335
SMILES和InChIs

SMILES:
O1C(CNC1=O)COc1cc(cc(c1)C)C
Canonical SMILES:
O=C1NCC(O1)COc1cc(C)cc(c1)C
InChI:
InChI=1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14)
InChIKey:
IMWZZHHPURKASS-UHFFFAOYSA-N

引用这个纪录

CBID:542 http://www.chembase.cn/molecule-542.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
5-(3,5-dimethylphenoxymethyl)-1,3-oxazolidin-2-one
5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one
IUPAC传统名
@metaxalone
metaxalone
商标名
Skelaxin
Zorane
别名
Metassalone [Dcit]
Metaxalon
Metaxalona [INN-Spanish]
Metaxalonum [INN-Latin]
Metaxalonum [Latin]
Methaxalonum
Methoxolone
Metazalone
Metazolone
Metaxalone
5-((3,5-Dimethylphenoxy)methyl)oxazolidin-2-one
5-[(3,5-Dimethylphenoxy)methyl]oxazolidin-2-one
AHR-438
Skelaxin
5-(3,5-dimethylphenoxymethyl)-1,3-oxazolidin-2-one
CAS号
1665-48-1
MDL号
MFCD00867700
PubChem SID
46506253
160964005
PubChem CID
15459
CHEMBL
1079604
Chemspider ID
14709
DrugBank ID
DB00660
KEGG ID
D00773
美国药典/FDA物质标识码
1NMA9J598Y
维基百科标题
Metaxalone
Medline Plus
a682010

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 13.1439085  质子受体
质子供体 LogD (pH = 5.5) 2.3718133 
LogD (pH = 7.4) 2.3718126  Log P 2.3718133 
摩尔折射率 59.322 cm3 极化性 23.08755 Å3
极化表面积 47.56 Å2 可自由旋转的化学键
里宾斯基五规则 true 
Log P 1.63  LOG S -2.24 
溶解度 1.28e+00 g/l 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
溶解度
Chloroform expand 查看数据来源
Methanol expand 查看数据来源
外观
White Solid expand 查看数据来源
熔点
121-123°C expand 查看数据来源
疏水性(logP)
2.145 expand 查看数据来源
2.3 expand 查看数据来源
保存条件
-20°C Freezer expand 查看数据来源
保存注意事项
IRRITANT expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
TSCA收录
false expand 查看数据来源
给药途径
Oral expand 查看数据来源
生物利用度
Unknown expand 查看数据来源
排泄
Renal expand 查看数据来源
半衰期
9.2 (± 4.8) hours expand 查看数据来源
代谢
Hepatic expand 查看数据来源
法定药品分级
Rx-only (US) expand 查看数据来源
妊娠期药物分类
C (US) expand 查看数据来源
纯度
95% expand 查看数据来源
95+% expand 查看数据来源
98% expand 查看数据来源
质检报告
下载链接 expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank Wikipedia Wikipedia TRC TRC
DrugBank -  DB00660 external link
Item Information
Drug Groups approved
Description Metaxalone (marketed by King Pharmaceuticals under the brand name Skelaxin?) is a muscle relaxant used to relax muscles and relieve pain caused by strains, sprains, and other musculoskeletal conditions. Its exact mechanism of action is not known, but it may be due to general central nervous system depression. It is considered to be a moderately strong muscle relaxant, with relatively low incidence of side effects. Skelaxin comes in an 800 mg scored tablet. It previously came in both 400 mg and 800 mg tablets. The 400 mg tablet has been discontinued. Possible side effects include nausea, vomiting, drowsiness and CNS side effects such as dizziness, headache, and irritability.
Indication For the treatment of painful peripheral musculoskeletal conditions and spasticity from upper motor neuron syndromes.
Pharmacology Metaxalone is a skeletal muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Metaxalone does not directly relax tense skeletal muscles in man.
Toxicity LD50=775mg/kg (Rat, oral); LD50=1690 mg/kg (Mouse, oral). When determining the LD50 in rats and mice, progressive sedation, hypnosis and finally respiratoryfailure were noted as the dosage increased. In dogs, no LD50 could be determined as the higher doses produced an emetic action in 15 to 30 minutes.
Affected Organisms
Humans and other mammals
Biotransformation Probably hepatic.
Absorption The absolute bioavailability of metaxalone from Skelaxin tablets is not known.
Half Life 9.2 (+/- 4.8) hours
Elimination Metaxalone is metabolized by the liver and excreted in the urine as unidentified metabolites.
Distribution * 800 L
Clearance * 68 +/- 50 L/h [Subjects received 1×400mg tablet under fasted conditions]
* 66 +/- 51 L/h [Subjects received 2×400 mg tablets under fasted conditions]
References
See S, Ginzburg R: Choosing a skeletal muscle relaxant. Am Fam Physician. 2008 Aug 1;78(3):365-70. [Pubmed]
Elenbaas JK: Centrally acting oral skeletal muscle relaxants. Am J Hosp Pharm. 1980 Oct;37(10):1313-23. [Pubmed]
External Links
Wikipedia
RxList
Drugs.com
Toronto Research Chemicals -  M225850 external link
It is a muscle relaxant used to relax muscles and relieve pain.

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • See S, Ginzburg R: Choosing a skeletal muscle relaxant. Am Fam Physician. 2008 Aug 1;78(3):365-70. Pubmed
  • Elenbaas JK: Centrally acting oral skeletal muscle relaxants. Am J Hosp Pharm. 1980 Oct;37(10):1313-23. Pubmed
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle